Reut Shema - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Reut Shema’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Patient Care,
- Health Care,
- Talent Management,
- Digital Therapeutics,
- Hospitals,
- Genetics,
- Healthcare Delivery,
- Alternative Medicine,
- Disruptive Innovation,
- Wellness,
- Fundraising,
- Investment Management,
- Healthcare Innovation,
- Strategic Partnerships,
- Life Science,
- Portfolio Management,
- Medical Technologies,
- Artificial Intelligence (AI),
- Israel-based Startups,
- Analytics,
- Business Development,
- Bioinformatics,
- Biotechnology,
- Medical Devices,
- Entrepreneurship,
- Electronic Health Records (EHR),
- Genomics,
- Health and Hospital Services,
- Precision Medicine,
- Innovation,
- Clinical Trials,
- FinTech,
- Consumer Internet,
- Personalized Medicine,
- Medical Diagnostics,
- Health Diagnostics,
- Market Intelligence,
- Digital Health,
- Medical,
- Big Data,
- Information Technology,
- B2B,
- Therapeutics,
- Health Tech,
- Media and Entertainment,
- Machine Learning,
- Pharmaceuticals,
- Healthcare Technology,
- Risk Management
Social media:
Past investments:
- CuResponse
- Karius
- AbSci
- CartiHeal
- Zebra Medical Vision
- Mammoth Biosciences
- DayTwo
- AtaCor Medical
- MiNA Therapeutics
- Ibex Medical Analytics
- NanoGhosts
- Theranica
- Scipher Medicine
- Seer
- Mobilion Systems
- Nobio
- MDClone
- Medial EarlySign
- SOPHiA GENETICS
- Vocalis Health
- Viracta Therapeutics
- Ayala Pharmaceuticals
- Igentify
- Nectin Therapeutics
- Apos Therapy
Investor Profile
Reut Shema is a Venture Capital, Angel Group, Private Equity Firm, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as CuResponse, Karius, AbSci, CartiHeal, Zebra Medical Vision, Mammoth Biosciences, DayTwoAtaCor Medical, MiNA Therapeutics, Ibex Medical Analytics, NanoGhosts, Theranica, Scipher Medicine, Seer, Mobilion Systems, Nobio, MDClone, Medial EarlySign, SOPHiA GENETICS, Vocalis Health, Viracta Therapeutics, Ayala Pharmaceuticals, Igentify, Nectin Therapeutics, Apos Therapy, . Over time, Reut Shema has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Reut Shema is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Talent Management, Digital Therapeutics, Hospitals, Genetics, Healthcare Delivery, Alternative Medicine, Disruptive Innovation, Wellness, Fundraising, Investment Management, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Israel-based Startups, Analytics, Business Development, Bioinformatics, Biotechnology, Medical Devices, Entrepreneurship, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Precision Medicine, Innovation, Clinical Trials, FinTech, Consumer Internet, Personalized Medicine, Medical Diagnostics, Health Diagnostics, Market Intelligence, Digital Health, Medical, Big Data, Information Technology, B2B, Therapeutics, Health Tech, Media and Entertainment, Machine Learning, Pharmaceuticals, Healthcare Technology, Risk Management may find it worthwhile to explore potential connections with Reut Shema, as their portfolio suggests a familiarity and interest in this area.
Understanding Reut Shema’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
